Wedge Pressure Catheter Market

Executive Summary

Wedge Pressure Catheter Market was valued at US $48.97 billion in 2021 and is projected to grow at 8.10% CAGR over the forecast period to reach US $78.12 billion by 2027. Wedge Pressure Catheter Market represented US $7.06 billion opportunity over 2019-2021 and estimated to create US $29.16 billion opportunity in 2027 over 2021.

Wedge Pressure Catheter from Consainsights analyses the Wedge Pressure Catheter Market in the Life Sciences industry over the forecast period to 2027.

Wedge Pressure Catheter research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Wedge Pressure Catheter segmentation includes Material, Application, End-User and Geography.

Based on the Material, the Wedge Pressure Catheter analysis covers Polyurethane, Nylon, Others.

In Material segment, Polyurethane segment has highest cagr growth of 7.17%.

Based on the Application, the Wedge Pressure Catheter analysis covers Pulmonary Artery, Central Venous, Ventricular, Others.

In Application segment, Central Venous segment has highest cagr growth of 7.17%.

Based on the End-User, the Wedge Pressure Catheter analysis covers Hospitals, Specialty Clinics, Others.

In End-User segment, Specialty Clinics segment has highest cagr growth of 7.17%.

Based on the region, the Wedge Pressure Catheter analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Alpha Medical Instruments LLC, Advanced Lifesciences Pvt Ltd, Teleflex Incorporated, DeRoyal Industries, ICU Medical Inc, Nolato AB, Edwards Lifesciences, B. Braun Melsungen AG, Merit Medical Systems Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Material

Introduction

In 2021, Nylon segment has the highest revenue of US $24.32 billion and is expected to grow at CAGR of 7.17% by 2027 Polyurethane segment has highest cagr growth of 7.17%.

Polyurethane

Polyurethane segment was valued at US $20.19 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $37.64 billion by 2027. Polyurethane segment represented US $3.40 billion opportunity over 2019-2021 and estimated to create US $14.05 billion opportunity in 2027 over 2021.

Nylon

Nylon segment was valued at US $20.82 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $38.81 billion by 2027. Nylon segment represented US $3.51 billion opportunity over 2019-2021 and estimated to create US $14.48 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.90 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $1.68 billion by 2027. Others segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.63 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Pulmonary Artery segment has the highest revenue of US $21.31 billion and is expected to grow at CAGR of 7.17% by 2027 Central Venous segment has highest cagr growth of 7.17%.

Pulmonary Artery

Pulmonary Artery segment was valued at US $18.24 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $34.00 billion by 2027. Pulmonary Artery segment represented US $3.07 billion opportunity over 2019-2021 and estimated to create US $12.69 billion opportunity in 2027 over 2021.

Central Venous

Central Venous segment was valued at US $10.58 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $19.73 billion by 2027. Central Venous segment represented US $1.78 billion opportunity over 2019-2021 and estimated to create US $7.36 billion opportunity in 2027 over 2021.

Ventricular

Ventricular segment was valued at US $8.60 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $16.02 billion by 2027. Ventricular segment represented US $1.45 billion opportunity over 2019-2021 and estimated to create US $5.98 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $4.49 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $8.37 billion by 2027. Others segment represented US $0.76 billion opportunity over 2019-2021 and estimated to create US $3.12 billion opportunity in 2027 over 2021.

End-User

Introduction

In 2021, Hospitals segment has the highest revenue of US $24.93 billion and is expected to grow at CAGR of 7.17% by 2027 Specialty Clinics segment has highest cagr growth of 7.17%.

Hospitals

Hospitals segment was valued at US $21.33 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $39.77 billion by 2027. Hospitals segment represented US $3.59 billion opportunity over 2019-2021 and estimated to create US $14.84 billion opportunity in 2027 over 2021.

Specialty Clinics

Specialty Clinics segment was valued at US $15.98 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $29.80 billion by 2027. Specialty Clinics segment represented US $2.69 billion opportunity over 2019-2021 and estimated to create US $11.12 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $4.59 billion in 2019 and is projected to grow at 7.17% CAGR over the forecast period to reach US $8.56 billion by 2027. Others segment represented US $0.77 billion opportunity over 2019-2021 and estimated to create US $3.19 billion opportunity in 2027 over 2021.